Media Summary: Jacqueline Garcia, MD, Dana-Farber Cancer Institute, Boston, MA, comments on Presentation lead by Dr. Donna Graves, Atrium Health. Presentation lead by Dr. Irena Dujmovic, Department of Neurology at UNC Chapel Hill.
Current And Emerging Treatment Options - Detailed Analysis & Overview
Jacqueline Garcia, MD, Dana-Farber Cancer Institute, Boston, MA, comments on Presentation lead by Dr. Donna Graves, Atrium Health. Presentation lead by Dr. Irena Dujmovic, Department of Neurology at UNC Chapel Hill. Ilaria Iacobucci, PhD, St. Jude Children's Research Hospital, Memphis, TN, discusses Claire Harrison, MD, FRCP, FRCPath, Guy's & St Thomas' NHS Foundation Trust, London, UK, discusses the Julia Driessen, MBBS, University of Amsterdam, Amsterdam, The Netherlands, discusses the limitations of
There is a great unmet need for harmonized, up-to-date clinical practice guidelines for the Francesco Passamonti, MD, University of Insubria, Varese, Italy, gives an overview of ... undetectable equals untransmittable those medications have been a GameChanger and probably the most Pankit Vachhani, MD, University of Alabama at Birmingham, Birmingham, AL, discusses the biology and Watch this summary video and read the full paper on ... Download the resources and collect credit -
Dr. Doris Hansen, a myeloma specialist from Moffitt Cancer Center, reviews the two FDA-approved CAR T-cell
